ANGPTL8 and obesity due to melanocortin 4 receptor deficiency: [5] Based on these results, betatrophin has now been suggested as a novel candidate for therapeutic approaches involving beta cell regeneration in diabetes.[6, 7] Recent studies in humans have revealed conflicting results with regard to betatrophin regulation in obesity and diabetes.